VAM
CRL icon

Visionary Asset Management’s Charles River Laboratories CRL Stock Holding History

Visionary Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$207K Sell
1,832
-71
-4% -$8.89K 0.08% 119
2018
Q3 		$256K Sell
1,903
-1
-0.1% -$123 0.08% 230
2018
Q2 		$214K Buy
+1,904
New +$206K 0.07% 257

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Visionary Asset Management's CRL Position: Q4 2018 in Review

Visionary Asset Management reduced its Charles River Laboratories (CRL) stake by 3.7% in Q4 2018, selling an estimated $8.89K and leaving 1,832 shares worth $207K. The position accounts for 0.08% of the portfolio, ranked #119.

Visionary Asset Management first reported a position in CRL in Q2 2018 and has held it in 3 quarters since. The position peaked at $256K in Q3 2018. 407 funds tracked by Wall St. Rank hold CRL as of Q4 2018.

  • Visionary Asset Management held 1,832 shares of Charles River Laboratories worth $207K as of Q4 2018.
  • Visionary Asset Management sold 71 Charles River Laboratories shares in Q4 2018, an estimated $8.89K.
  • Charles River Laboratories made up 0.08% of Visionary Asset Management's portfolio in Q4 2018, its #119 holding.
  • Visionary Asset Management first reported a position in Charles River Laboratories in Q2 2018 and has held it in 3 quarters since.
  • Visionary Asset Management's Charles River Laboratories position peaked at $256K in Q3 2018.
  • 407 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2018.

Based on Visionary Asset Management's 13F filing for Q4 2018, filed 11 Jan 2019.